A BIZARRE PROGRESSION OF CHRONIC LYMPHOCYTIC LEUKAEMIA INTO DIFFUSE LARGE B-CELL LYMPHOMA
DOI:
https://doi.org/10.55519/JAMC-03-11640Abstract
A 65-year-old male presented with complaints of weakness, lethargy, abdominal pain, and low-grade fever for the last few months. His examination revealed generalized lymphadenopathy and splenomegaly. A subsequent laboratory workup revealed atypical lymphoid cells with prominent double-bright positivity of CD19 and CD5 markers. Further investigations revealed deletion of the ATM (11q22.3) gene, and in accordance with other diagnostic factors, the patient was diagnosed with B-cell chronic lymphocytic leukaemia. Thus, treatment was initiated with oral chemotherapy followed by rituximab-bendamustine. After three weeks, he presented to the emergency room with a fever and worsening abdominal pain. On examination, massive splenomegaly was found. After stabilization, a bone marrow biopsy revealed findings which, in light of the clinical symptoms, were consistent with Richter’s transformation of B-Cell chronic lymphocytic leukaemia into Diffuse large B-Cell LymphomaReferences
Sitlinger A, Deal MA, Garcia E. Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia. Cells 2021;10(5):1165
Kikushige Y. Pathophysiology of chronic lymphocytic leukemia and human B1 cell development. Int J Hematol 2020;111(5):634–41.
Tian Z, Liu M, Fang X, Zhou X, Li P, Li Y, Zhang L, et al. Distinct Age-Related Clinical Features and Risk Assessment in Chinese With Chronic Lymphocytic Leukemia. Front Oncol 2022;12:885150.
Marionneaux SM, Keohane EM, Lamanna N, King TC, Mehta SR. Smudge Cells in Chronic Lymphocytic Leukemia: Pathophysiology, Laboratory Considerations, and Clinical Significance. Lab Med 2021;52(5):426–38.
Barnea Slonim L, Ma S, Behdad A, Chen Q. Pseudo-Richter transformation of chronic lymphocytic leukamia/small lymphocytic lymphoma following ibrutinib interruption: a diagnostic pitfall. Br J Haematol 2020;191(1)e22–5.
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, v Tresckow J, et al. Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia 2021;35(1):169–76.
Tadmor T, Levy I. Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents. Cancers 2021;13(20):5141.
Rossi D, Spina V, Gaidano G. Biology and treatment of Richter syndrome. Blood 2018;131(25):2761–72.
Additional Files
Published
Issue
Section
License
Copyright (c) 2023 Danish Shakeel , Hira Qadir, Mahad Mirza Baig, Shah Mureed Ojla
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.